HPV and head and neck cancer

Area of Science:

• Oncology
• Virology
• Genetics

Background:

• Oropharyngeal cancer incidence is increasing globally, particularly HPV type-16 related cases.
• HPV-positive oropharyngeal cancers present distinct clinical and biologic features, including earlier onset and specific histopathology.
• Identifying intratumoral human papillomavirus (HPV) is crucial for diagnosis and patient stratification.

Purpose of the Study:

• To highlight the increasing role of oncogenic HPV in head and neck cancers.
• To emphasize the distinct characteristics and improved prognosis of HPV-positive oropharyngeal carcinoma.
• To discuss diagnostic methods and future directions in HPV-related oropharyngeal cancer research.

Main Methods:

• Detection of intratumoral oncogenic HPV DNA using Polymerase Chain Reaction (PCR) with hybridization.
• Analysis of E6/E7 mRNA expression as a key indicator for patient stratification.
• Comparative analysis of clinical and biologic profiles between HPV-positive and HPV-negative oropharyngeal carcinoma patients.

Main Results:

• PCR with hybridization is the most sensitive and widely used method for detecting intratumoral HPV DNA.
• HPV-positive oropharyngeal carcinoma is associated with a better prognosis regarding survival and locoregional control compared to smoking/alcohol-related cases.
• Patients with HPV-positive oropharyngeal cancer exhibit unique characteristics such as earlier onset and specific histopathological findings.

Conclusions:

• HPV type-16 plays a significant role in the rising incidence of oropharyngeal cancers.
• HPV-positive oropharyngeal carcinoma demonstrates a more favorable prognosis than traditional risk factor-associated cancers.
• Vaccination strategies warrant further investigation to assess their impact on oropharyngeal carcinoma rates.